Literature DB >> 3201202

Studies of intestinal lymphoid tissue. XI--The immunopathology of cell-mediated reactions in gluten sensitivity and other enteropathies.

M N Marsh1.   

Abstract

Computerised image-analysis was used to quantitate small intestinal mucosae from celiac sprue and dermatitis herpetiformis patients, Gambian children with tropical-sprue-like malabsorption, first-degree celiac sprue relatives, and treated celiac sprue patients during challenge with a peptic-tryptic digest of gluten. A wide range of mucosal appearances was observed. Typically, 'flat' lesions (Type 2) revealed a reduced number of epithelial lymphocytes that were large and mitotically active. At the other extreme, mucosal architecture was relatively well preserved (Type 1) but surface epithelium contained an expanded population of small, non-mitotic lymphocytes, with or without crypt hyperplasia. Similar changes were observed in one-third of celiac relatives and following small dose gluten challenge. Larger dose challenges revealed a transition from Type 1 to Type 2 lesions over a 5-day period. Studies in a few patients over 2-4 years showed a similar type of progression. A major feature of this sequence was early appearance of crypt hypertrophy while villi persisted, indicating a role for factors other than increased loss of enterocytes from surface epithelium. These changes parallel the T lymphocyte-mediated events in graft-versus-host reactions in animals. It is thus concluded that the spectrum of immunopathologic changes observed in gluten sensitivity is fundamentally a cell-mediated effect, the degree of change being controlled by host genetic factors. In becoming flat, it appears obligatory for the mucosa to evolve through the earlier Type 1 lesion in which crypt hypertrophy is a prominent response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3201202

Source DB:  PubMed          Journal:  Scanning Microsc        ISSN: 0891-7035


  19 in total

1.  Macrophage procoagulant activity as an assay of cellular hypersensitivity to gluten peptides in coeliac disease.

Authors:  J M Devery; C L Geczy; D DeClarle; J H Skerritt; S A Krillis
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Compliance of adolescents with coeliac disease with a gluten free diet.

Authors:  M Mayer; L Greco; R Troncone; S Auricchio; M N Marsh
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

Review 3.  Grains of truth: evolutionary changes in small intestinal mucosa in response to environmental antigen challenge.

Authors:  M N Marsh
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

4.  Natural killer cell activity in coeliac disease: effect of in vitro treatment on effector lymphocytes and/or target lymphoblastoid, myeloid and epithelial cell lines with gliadin.

Authors:  M A Castany; H H Nguyen; M Pospísil; P Fric; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

5.  Platelet-to-lymphocyte ratio for early diagnosis of celiac disease.

Authors:  Murat Sarikaya; Zeynal Dogan; Bilal Ergul; Levent Filik
Journal:  Indian J Gastroenterol       Date:  2014-08-16

6.  Morphometric analysis of intestinal mucosa. V. Quantitative histological and immunocytochemical studies of rectal mucosae in gluten sensitivity.

Authors:  A Ensari; M N Marsh; D E Loft; S Morgan; K Moriarty
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

Review 7.  Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential.

Authors:  A Ferguson; E Arranz; S O'Mahony
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

8.  Screening for coeliac disease: the meaning of low titers of anti-gliadin antibodies (AGA) in non-coeliac children.

Authors:  M Bonamico; G Ballati; P Mariani; M Latini; P Triglione; I Rana; E Porro; M A Mesturino; S Criscione
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

9.  Animal model of gluten induced enteropathy in mice.

Authors:  R Troncone; A Ferguson
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

10.  Predominance of T cell receptor V delta 3 in small bowel biopsies from coeliac disease patients.

Authors:  M C Falk; G NG; G Y Zhang; G C Fanning; K R Kamath; J F Knight
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.